Amplifon (AMP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
H1 2024 revenues grew 5.7% year-over-year to €1,177.3 million, with 8% growth at constant FX, driven by 4.6% organic growth and 3.4% from acquisitions, despite European market softness.
Recurring EBITDA rose 7.7% to €297.2 million, margin up 40 bps to 25.2%, supported by field productivity and offsetting US retail margin dilution.
Net profit increased to €90.3 million recurring, with a margin of 7.7%, and recurring net profit for Q2 was €54.6 million.
Net financial debt rose to €1,009.3 million, leverage at 1.70x, mainly due to higher M&A, capex, and dividend payments.
Added 290 points of sale globally in H1, mainly in France, Germany, North America, China, and Uruguay.
Financial highlights
Q2 2024 revenues reached €604.1 million, up 7.1% at constant FX and 5.3% at current FX; organic growth 3.5%, M&A 3.6%.
H1 recurring EBITDA margin improved by 40 bps to 25.2%; Q2 recurring EBITDA was €160.4 million (26.6% margin).
H1 recurring EBIT was €152.4 million (+3.3% y/y); adjusted EPS for H1 was €0.495 (+2.2% y/y).
Free cash flow for H1 was €46.8 million, down from €76.1 million in H1 2023, impacted by higher taxes, rents, and working capital absorption.
FX headwinds, especially from the Argentine peso, AUD, and NZD, impacted results.
Outlook and guidance
Expects high single-digit revenue growth at constant FX for 2024, with bolt-on acquisitions contributing at least 2%.
Recurring EBITDA margin expected around 24.3%, reflecting productivity measures and offsetting US retail margin dilution.
European market anticipated to normalize and return to growth in H2; US market to maintain healthy growth at 6%-7%.
Medium-term outlook remains positive for sustainable sales and profitability growth.
Margin guidance trimmed by 30 bps to reflect Q2 performance, US network transformation, and potential higher marketing spend if European softness persists.
Latest events from Amplifon
- A €2.3B deal forms a global audiology leader, targeting €60–80M synergies by 2029.AMP
M&A announcement17 Mar 2026 - Revenue up 1.7% at constant FX; Fit4Growth drives margin gains amid market headwinds.AMP
Q4 20254 Mar 2026 - Revenue up 8% at constant FX to €1.74bn, net profit €104.2m, outlook for high single-digit growth.AMP
Q3 202417 Jan 2026 - 2024 saw 7% revenue growth and margin investment; 2025 targets 5–9% growth and higher profitability.AMP
Q4 202415 Dec 2025 - Q1 2025 delivered record EBITDA margin, 2.6% revenue growth, and guidance confirmation.AMP
Q1 202518 Nov 2025 - Q3 organic growth returned, but margins and profit fell; FY2025 targets modest gains.AMP
Q3 20256 Nov 2025 - Margins fell as revenue growth slowed, prompting a new margin improvement program.AMP
Q2 202530 Oct 2025